NCT00573066View on ClinicalTrials.gov

Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Hypoplastic Left HeartTetralogy of FallotTricuspid Atresia
Interventions
DRUG

Dexmedetomidine

Dosage levels: Dose Level 1: Loading dose 0.35mcg/kg and CIVI 0.25mcg/kg/hr Dose Level 2: Loading Dose of 0.7mcg/kg and CIVI 0.5mcg/kg/hr and Dose Level 3: Loading Dose 1 mcg/kg and CIVI 0.75 mcg/kg/hr.

All Listed Sponsors
lead

Athena Zuppa

OTHER

NCT00573066 - Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery | Biotech Hunter | Biotech Hunter